Panbela Therapeutics (PBLA) Short Interest Ratio & Short Volume $0.16 0.00 (0.00%) As of 11:24 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFDA EventsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Panbela Therapeutics Short Interest DataPanbela Therapeutics (PBLA) has a short interest of 100 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a -50.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 16,227 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest200 sharesChange Vs. Previous Month-50.00%Dollar Volume Sold Short$17.00Short Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares4,855,000 sharesShort Percent of Float0.00%Today's Trading Volume501 sharesAverage Trading Volume16,227 sharesToday's Volume Vs. Average3% Short Selling Panbela Therapeutics? Sign up to receive the latest short interest report for Panbela Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPBLA Short Interest Over TimePBLA Days to Cover Over TimePBLA Percentage of Float Shorted Over Time Panbela Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025100 shares $17.00 -50.0%0.0%0 $0.17 7/15/2025200 shares $47.88 +100.0%N/A0 $0.24 6/30/2025100 shares $23.19 -50.0%0.0%0 $0.23 6/15/2025200 shares $60.00 No Change0.0%0 $0.30 5/31/2025200 shares $51.60 +100.0%0.0%0 $0.26 5/15/2025100 shares $30.00 -93.8%N/A0 $0.30 4/30/20251,600 shares $424.00 No ChangeN/A0.1 $0.27 4/15/2025100 shares $31.30 -66.7%N/A0 $0.31 3/14/2025300 shares $111.30 -95.5%N/A0 $0.37 2/14/2025300 shares $102.00 -25.0%N/A0 $0.34 Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025400 shares $140.00 -94.0%N/A0 $0.35 1/15/20256,700 shares $2.81 thousand +6,600.0%N/A0.1 $0.42 2/29/2024114,700 shares $135.35 thousand +7.2%2.4%0.1 $1.18 2/15/2024107,000 shares $135.89 thousand -39.8%2.2%0.1 $1.27 1/31/2024177,700 shares $247.00 thousand +283.0%3.7%0.3 $1.39 1/15/202446,400 shares $584.64 thousand -96.6%9.7%0.2 $12.60 12/31/20231,350,000 shares $1.24 million +1,319.6%14.1%0.3 $0.92 12/15/202395,100 shares $43.47 thousand +115.7%1.9%0 $0.46 11/30/202344,100 shares $23.37 thousand -32.1%0.9%0 $0.53 11/15/202364,900 shares $39.13 thousand -22.2%1.3%0.1 $0.60 10/31/202383,400 shares $66.90 thousand +22.5%2.8%0.1 $0.80 10/15/202368,100 shares $70.14 thousand -21.5%2.3%0.6 $1.03 9/30/202386,700 shares $113.58 thousand -18.2%3.0%0.1 $1.31 9/15/2023106,000 shares $139.92 thousand +26.6%3.6%0.1 $1.32 8/31/202383,700 shares $116.34 thousand +335.9%2.9%0.1 $1.39 8/15/202319,200 shares $28.80 thousand -60.5%0.7%0 $1.50 7/31/202348,600 shares $97.69 thousand +102.5%1.7%0.1 $2.01 7/15/202324,000 shares $49.92 thousand -74.6%0.9%0 $2.08 6/30/202394,600 shares $217.58 thousand -50.3%3.4%0.4 $2.30 6/15/2023190,500 shares $1.11 million +590.2%6.9%0.9 $5.81 5/31/202327,600 shares $186.38 thousand -96.3%5.1%0.2 $6.75 5/15/2023754,400 shares $309.30 thousand -59.9%N/A0.3 $0.41 4/30/20231,880,000 shares $1.03 million -23.0%N/A0.6 $0.55 4/15/20232,440,000 shares $1.39 million +611.6%N/A0.9 $0.57 3/31/2023342,900 shares $151.63 thousand +3.9%N/A0.1 $0.44 3/15/2023330,200 shares $219.55 thousand -61.6%N/A0.2 $0.66 2/28/2023859,300 shares $1.18 million -18.2%13.7%0.5 $1.37 2/15/20231,050,000 shares $1.52 million +596.8%16.7%0.7 $1.45 1/31/2023150,700 shares $247.15 thousand -63.9%2.5%0.1 $1.64 1/15/2023417,700 shares $1.39 million -67.4%55.4%1.2 $3.32Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 12/30/20221,280,000 shares $93.82 thousand +60.5%N/A0.2 $0.07 12/15/2022797,500 shares $77.36 thousand +227.1%N/A0.2 $0.10 11/30/2022243,800 shares $33.01 thousand +354.9%N/A0.2 $0.14 11/15/202253,600 shares $8.52 thousand +51.8%N/A0.1 $0.16 10/31/202235,300 shares $4.47 thousand -23.9%N/A0 $0.13 10/15/202246,400 shares $10.35 thousand -95.6%N/A0.1 $0.22 9/30/20221,050,000 shares $283.82 thousand +276.9%N/A1.7 $0.27 9/15/2022278,600 shares $105.59 thousand +101.0%N/A0.5 $0.38 8/31/2022138,600 shares $95.74 thousand +9.4%N/A2.4 $0.69 8/15/2022126,700 shares $150.77 thousand -24.0%N/A2.7 $1.19 7/31/2022166,700 shares $206.71 thousand -4.9%N/A3.7 $1.24 7/15/2022175,300 shares $194.58 thousand +19.7%N/A3.9 $1.11 6/30/2022146,400 shares $96.64 thousand -4.6%N/A3.1 $0.66 6/15/2022153,500 shares $193.41 thousand +1.2%N/A4.4 $1.26 5/31/2022151,700 shares $227.55 thousand +31.0%N/A8.6 $1.50 5/15/2022115,800 shares $185.53 thousand -18.6%N/A4.1 $1.60 4/30/2022142,200 shares $251.69 thousand -14.3%N/A4.3 $1.77 4/15/2022165,900 shares $328.48 thousand +3.3%N/A4.5 $1.98 3/31/2022160,600 shares $338.87 thousand +9.9%N/A4.3 $2.11 3/15/2022146,200 shares $248.54 thousand -15.3%N/A3.2 $1.70 2/28/2022172,600 shares $336.57 thousand +21.8%N/A3.3 $1.95 2/15/2022141,700 shares $317.41 thousand -18.1%N/A2.4 $2.24 1/31/2022173,100 shares $368.70 thousand -6.2%N/A3.1 $2.13 1/15/2022184,600 shares $304.59 thousand -17.7%N/A3.3 $1.65 12/31/2021224,200 shares $387.89 thousand +18.9%N/A4.1 $1.73 12/15/2021188,600 shares $330.05 thousand -10.6%N/A3.7 $1.75 11/30/2021211,000 shares $390.35 thousand +5.3%N/A4.1 $1.85 11/15/2021200,300 shares $426.64 thousand -0.7%N/A3.5 $2.13 10/29/2021201,800 shares $431.85 thousand -1.5%N/A3.6 $2.14 10/15/2021204,900 shares $405.70 thousand +5.2%N/A1.6 $1.98 9/30/2021194,800 shares $422.72 thousand -9.4%N/A1.3 $2.17 9/15/2021214,900 shares $472.78 thousand -2.5%N/A0.9 $2.20 8/31/2021220,500 shares $500.54 thousand -14.7%N/A0.9 $2.27 8/13/2021258,400 shares $607.24 thousand +5.7%N/A1.1 $2.35 7/30/2021244,400 shares $615.89 thousand +12.5%N/A1 $2.52 7/15/2021217,200 shares $562.55 thousand -35.5%N/A1.3 $2.59 6/30/2021336,500 shares $952.30 thousand +85.2%N/A2.1 $2.83 6/15/2021181,700 shares $675.92 thousand -6.2%2.2%2.7 $3.72 5/28/2021193,800 shares $813.96 thousand +6.9%2.3%3 $4.20 5/14/2021181,300 shares $692.57 thousand -14.0%2.2%3.2 $3.82 4/30/2021210,900 shares $982.79 thousand +18.2%2.5%1.8 $4.66 4/15/2021178,400 shares $713.60 thousand -5.2%2.1%1.1 $4.00 3/31/2021188,100 shares $769.33 thousand -3.9%2.3%1.2 $4.09 3/15/2021195,700 shares $884.56 thousand +16.6%2.4%1.2 $4.52 2/26/2021167,800 shares $740.00 thousand -12.2%2.2%0.8 $4.41 2/12/2021191,000 shares $1.03 million +38.3%2.5%1 $5.38 1/29/2021138,100 shares $760.24 thousand +78.9%1.8%0.9 $5.51 1/15/202177,200 shares $633.04 thousand No Change1.0%0.8 $8.20 PBLA Short Interest - Frequently Asked Questions What is Panbela Therapeutics' current short interest? Short interest is the volume of Panbela Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 100 shares of PBLA short. 0.00% of Panbela Therapeutics' shares are currently sold short. Learn More on Panbela Therapeutics' current short interest. What is a good short interest percentage for Panbela Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Panbela Therapeutics' floating shares are currently sold short. Is Panbela Therapeutics' short interest increasing or decreasing? Panbela Therapeutics saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 100 shares, a drop of 50.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Panbela Therapeutics' short interest compare to its competitors? 0.00% of Panbela Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Panbela Therapeutics: Redhill Biopharma Ltd. (4.68%), CNS Pharmaceuticals, Inc. (7.71%), Lipella Pharmaceuticals Inc. (0.10%), Qualigen Therapeutics, Inc. (3.51%), SciSparc Ltd. (2.53%), PainReform Ltd. (7.21%), PMGC Holdings Inc. (7.84%), Enveric Biosciences, Inc. (11.92%), Heatwurx Inc. (10.33%), Galmed Pharmaceuticals Ltd. (2.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Panbela Therapeutics stock? Short selling PBLA is an investing strategy that aims to generate trading profit from Panbela Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Panbela Therapeutics? A short squeeze for Panbela Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBLA, which in turn drives the price of the stock up even further. How often is Panbela Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBLA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Redhill Biopharma Short Interest Data CNS Pharmaceuticals Short Interest Data Lipella Pharmaceuticals Short Interest Data Qualigen Therapeutics Short Interest Data SciSparc Short Interest Data PainReform Short Interest Data PMGC Short Interest Data Enveric Biosciences Short Interest Data Heatwurx Short Interest Data Galmed Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBLA) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access